Sterling Pharma Solutions

Sterling Pharma Solutions

About

Company description

Sterling Pharma Solutions (SPS) is a leading API CDMO. From US FDA, MHRA and PMDA approved facilities; SPS can handle the most hazardous chemistries at a range of scales. We are passionate about providing a customer focused and service driven approach to offer flexible and tailored solutions to our clients.

Quick facts

Affiliated categories: API Contract Manufacturing |Chiral Intermediates |Contract Manufacturing More

Upcoming events

13 oct 2020

CPhI Worldwide 2020

13 - 15 October 2020 Milan, Italy Visit us at stand 7H51 Book a meeting See our Exhibitor Profile   See full Exhibitor List

Recently at

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany We were at stand 101A60 See our Exhibitor Profile   See full Exhibitor List
30 apr 2019

CPhI North America 2019

30 April - 2 May 2019 Chicago, USA We were at stand 1112 See our Exhibitor Profile   See full Exhibitor List

News about Sterling Pharma Solutions

Sterling pilot plant facility expansion up and running

4 Jun 2019

Sterling pilot plant facility expansion up and running

Additional three new reactor trains will help the CDMO to meet growing market demand for smaller API batch sizes.

Read more

9 Apr 2019

Sterling Pharma to acquire CiVentiChem in the US

The acquisition will enhance the CDMO's chemistry development capabilities to support pre-clinical and early phase clinical supply.

Read more

16 Mar 2019

Specialist API CDMO acquired by GHO Capital

Future plan is to extend Sterling’s international presence to meet increasing demand from customers worldwide.

Read more

24 Apr 2018

Sterling Pharma Solutions experiences record US growth

The CDMO's US sales have increased from £15.5 million to £41 million since 2016.

Read more
Sterling Pharma Solutions

Contact information

Address

Telephone

Website

View all contact information